Skip to main content
Log in

Pharmaceutical Care Network Europe (PCNE) drug-related problem classification version 9.00: German translation and validation

  • Short Research Report
  • Published:
International Journal of Clinical Pharmacy Aims and scope Submit manuscript

Abstract

Background The drug-related problem classification system of the Pharmaceutical Care Network Europe (PCNE) is well established and continuously updated. A translated version of the drug-related problem classification system can facilitate research and implementation of clinical pharmacy services in the corresponding countries. Aim This study aimed to translate and validate the current version 9.00 into German language. Method The forward–backward translation method was used to translate the English version 9.00 into German language. Validation was done with 20 patient cases. Consistency was calculated in percentage and compared to international results. Results Translation of the classification system yielded in a German version. Validation was done with 32 pharmacists and 20 patient cases. In the five primary domains, average consistencies of 77.3% (problem), 57.8% (cause), 57.4% (intervention), 74.5% (acceptance) and 74.9% (status) were achieved. Ambiguities were found in some patient cases, as raters came to differing but plausible codes. Conclusions This study provides a German translation of the PCNE classification for drug related problems of approximately similar consistency as the international version. It hence can be considered to classify drug-related problems in German speaking countries. Patient cases need to be more specific in future validations, feasibility and layout of the classification system need to improve.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

References

  1. Hepler CD, Strand LM. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm. 1990;47:533–43.

    CAS  PubMed  Google Scholar 

  2. Williams M, Peterson GM, Tenni PC, Bindoff IK, Stafford AC. DOCUMENT: a system for classifying drug-related problems in community pharmacy. Int J Clin Pharm. 2012;34:43–52.

    Article  Google Scholar 

  3. Maes KA, Tremp RM, Hersberger KE, Lampert ML. Demonstrating the clinical pharmacist’s activity: validation of an intervention oriented classification system. Int J Clin Pharm. 2015;37:1162–71.

    Article  Google Scholar 

  4. van Mil JWF, Westerlund LOT, Hersberger KE, Schaefer MA. Drug-related problem classification systems. Ann Pharmacother. 2004;38:859–67.

    Article  Google Scholar 

  5. Horvat N, Kos M. Development and validation of the Slovenian drug-related problem classification system based on the PCNE classification V 6.2. Int J Clin Pharm. 2016;38:950–9.

    Article  CAS  Google Scholar 

  6. Eichenberger PM, Lampert ML, Kahmann IV, van Mil JWF, Hersberger KE. Classification of drug-related problems with new prescriptions using a modified PCNE classification system. Pharm World Sci. 2010;32:362–72.

    Article  Google Scholar 

  7. Koubaity M, Lelubre M, Sansterre G, Amighi K, Vriese C de. Adaptation and validation of PCNE drug-related problem classification v6.2 in French-speaking Belgian community pharmacies. Int J Clin Pharm. 2019;41:244–50.

    Article  CAS  Google Scholar 

  8. Pharmaceutical Care Network Europe. Classification for drug related problems. https://www.pcne.org/upload/files/334_PCNE_classification_V9-0.pdf. Accessed 2 Sept 2020.

  9. Horvat N. PCNE working group on drug-related problems. Final report. 2020. https://www.pcne.org/upload/files/411_2020-05-04_Final_Report_online_validation_PCNE_classification.pdf. Accessed 2 Sept 2020.

  10. Pharmaceutical Care Network Europe Association. PCNE Klassifikation arzneimittelbezogener Probleme V9.00. https://www.pcne.org/upload/files/343_PCNE_V9.0_German_translation.pdf. Accessed 2 Sept 2020.

Download references

Acknowledgements

The authors like to thank Ms. Olga Grintsova for her participation in the translation process, the members of the PCNE DRP group for the close collaboration and the participating pharmacists for their commitment and time.

Funding

This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Olaf Rose.

Ethics declarations

Conflicts of interest

Elisabeth Schindler declares no conflict of interest. Ina Richling has received a speaker honorarium from Tilray, Gehe, Dr. Pöhnl, Univadis, Hexal, KWHC, Bionorica and Pfizer. Olaf Rose has received a speaker honorarium from AbbVie, MSD Sharp & Dohme, Novartis and Omnicell.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Schindler, E., Richling, I. & Rose, O. Pharmaceutical Care Network Europe (PCNE) drug-related problem classification version 9.00: German translation and validation. Int J Clin Pharm 43, 726–730 (2021). https://doi.org/10.1007/s11096-020-01150-w

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11096-020-01150-w

Keywords

Navigation